Lipid-Lowering, Antidiabetic Drugs Tied to Prevalence of AMD
TUESDAY, Nov. 8, 2022 (HealthDay News) -- Lipid-lowering drugs (LLDs) and antidiabetic drugs are associated with lower prevalence of any age-related macular degeneration (AMD), according to a meta-analysis published online Nov. 7 in the British Journal of Ophthalmology.
Matthias M. Mauschitz, M.D., Ph.D., from the University Hospital Bonn in Germany, and colleagues examined the association of commonly used systemic medications with prevalent AMD among 38,694 adults from 14 population- and hospital-based studies from the European Eye Epidemiology consortium.
The mean age ranged from 61.5 ± 7.1 to 82.6 ± 3.8 years between studies, and prevalence varied from 12.1 to 64.5 percent and from 0.5 to 35.5 percent for any and late AMD, respectively. The researchers found that LLDs and antidiabetic drugs were associated with reduced prevalence of any AMD (odds ratios, 0.85 and 0.78, respectively). No association was seen with late AMD or with any other medication.
"Given a potential interference of these drugs with pathophysiological pathways relevant in AMD, this may contribute to a better understanding of AMD etiology. Further longitudinal studies are needed to confirm or refute these associations," the authors write.
One of the studies included in the analyses received financial support from Laboratoires Théa.
Related Posts
FDA Sends Warning to Companies Selling THC Products That Look Like Candy, Cookies
WEDNESDAY, July 5, 2023 (HealthDay News) -- Several companies are selling...
COVID-19 Death After Menopause Down With Increased Estrogen Level
TUESDAY, Feb. 15, 2022 (HealthDay News) -- For postmenopausal women, estrogen...
Autism Screening Tool Accurate in Infants to Preschoolers
THURSDAY, March 17, 2022 (HealthDay News) -- The Social Attention and...
How Much Weight Loss Per Month Is Safe?
THURSDAY, Jan. 12, 2023 (HealthDay News) -- So, after a month of holiday eating,...